Decreased expression of miR-29a is also reported in GSCs, which normally acts as a tumor suppressor by inhibiting expression of Quaking gene isoform 6 involved in the PI3K/Akt signaling pathway [196]. The gene discussed is AKT1; the disease is neoplasm.